Compare TRST & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TRST | DNA |
|---|---|---|
| Founded | 1902 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 699.3M | 562.3M |
| IPO Year | N/A | N/A |
| Metric | TRST | DNA |
|---|---|---|
| Price | $42.41 | $9.16 |
| Analyst Decision | | Strong Sell |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $9.00 |
| AVG Volume (30 Days) | 102.4K | ★ 1.1M |
| Earning Date | 01-20-2026 | 11-06-2025 |
| Dividend Yield | ★ 3.58% | N/A |
| EPS Growth | ★ 21.05 | N/A |
| EPS | ★ 3.00 | N/A |
| Revenue | ★ $181,464,000.00 | $180,606,000.00 |
| Revenue This Year | $13.13 | N/A |
| Revenue Next Year | N/A | $7.28 |
| P/E Ratio | $14.54 | ★ N/A |
| Revenue Growth | ★ 7.63 | N/A |
| 52 Week Low | $27.18 | $5.00 |
| 52 Week High | $43.96 | $17.58 |
| Indicator | TRST | DNA |
|---|---|---|
| Relative Strength Index (RSI) | 63.73 | 45.00 |
| Support Level | $41.25 | $8.56 |
| Resistance Level | $43.96 | $9.38 |
| Average True Range (ATR) | 1.08 | 0.55 |
| MACD | 0.15 | 0.26 |
| Stochastic Oscillator | 74.07 | 69.31 |
Trustco Bank Corp N Y is a savings and loan holding company. The core part of a business consists of accepting deposits and making loans and investments. It offers a range of both personal and business banking services. The company's product includes savings accounts; retirement accounts; money market account; mortgages; building loans; auto loans and others. The company based on only one business segment, that of community banking. TrustCo lends in the geographic territory of its branch locations in New York, Florida, Massachusetts, New Jersey, and Vermont.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.